TerrAscend (TSNDF) Notes Payables (2024 - 2026)

TerrAscend's (TSNDF) quarterly Notes Payables came in at $56000.0 in Q1 2026, down 39.78% year-on-year from $93000.0 in Q1 2025, and down 94.21% on a QoQ basis from $967000.0 in Q4 2025.

TerrAscend (TSNDF) Notes Payables (2024 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 3 years of Notes Payables data on file, last reported at $56000.0 in Q1 2026.

  • On a quarterly basis, Notes Payables fell 39.78% year-over-year to $56000.0 in Q1 2026; TTM through Mar 2026 was $56000.0, a 39.78% decrease from a year earlier, with the FY2025 full-year figure at $967000.0, up 951.09% from the prior year.
  • Notes Payables for Q1 2026 stood at $56000.0, down from $967000.0 in the prior quarter.
  • Over the last five years, Notes Payables for TSNDF reached as high as $9.1 million in Q1 2024 and fell as low as $56000.0 in Q1 2026.
  • Historically, Notes Payables has averaged $2.0 million across 3 years, with a median of $756000.0 in 2024.
  • On a YoY basis, Notes Payables climbed as much as 951.09% in 2025 and fell as far as 98.98% in 2025.
  • Year by year, Notes Payables stood at $92000.0 in 2024, then soared by 951.09% to $967000.0 in 2025, then plunged by 94.21% to $56000.0 in 2026.
  • Per Business Quant data, the three most recent Notes Payables figures were $56000.0 in Q1 2026, $967000.0 in Q4 2025, and $893000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 TerrAscend 160.44 Mn 162.98 Mn 34.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 56,000.00
Dec 31, 2025 967,000.00
Sep 30, 2025 893,000.00
Jun 30, 2025 178,000.00
Mar 31, 2025 93,000.00
Dec 31, 2024 92,000.00
Sep 30, 2024 756,000.00
Jun 30, 2024 6.24 Mn
Mar 31, 2024 9.12 Mn